作者：
Zelenetz, Andrew D. [1]
;
Salles, Gilles [2]
;
Mason, Kylie D. [3]
;
Casulo, Carla [4]
;
Le Gouill, Steven [5]
;
Sehn, Laurie H. [6]
;
Tilly, Herve [7]
;
Cartron, Guillaume [8]
;
Chamuleau, Martine E. D. [9]
;
Goy, Andre [10]
;
Tam, Constantine S. [11]
;
Lugtenburg, Pieternella J. [12]
;
Petrich, Adam M. [13]
;
Sinha, Arijit [14]
;
Samineni, Divya [15]
;
Herter, Sylvia [16]
;
Ingalla, Ellen [17]
;
Szafer-Glusman, Edith [18]
;
Klein, Christian ;
Sampath, Deepak ;
Kornacker, Martin ;
Mobasher, Mehrdad ;
Morschhauser, Franck
作者单位：
Vrije Univ Amsterdam Med Ctr, HOVON Lunenburg Lymphoma Phase 1 2 Consortium, Amsterdam, Netherlands
[1]
Hosp Civils Lyon, Lyon, France
[2]
Roche Innovat Ctr Zurich, Roche Pharmaceut Res & Early Dev, Schlieren, Switzerland
[3]
Genentech Inc, San Francisco, CA 94080 USA
[4]
BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada
[5]
CHU Nantes, Serv Hematol, Nantes, France
[6]
Erasmus MC Canc Inst, HOVON Lunenburg Lymphoma Phase 1 2 Consortium, Rotterdam, Netherlands
[7]
Royal Melbourne Hosp, Melbourne, Vic, Australia
[8]
AbbVie, N Chicago, IL USA
[9]
Mem Sloan Kettering Canc Ctr, 1275 York Ave,Box 330, New York, NY 10065 USA
[10]
Ctr Henri Becquerel, Rouen, France
[11]
Univ Lille, Grp Rech Formes Injectables & Technol Associees, CHU Lille, Lille, France
[12]
Univ Montpellier, Dept Hematol, Montpellier, France
[13]
F Hoffmann La Roche Ltd, Basel, Switzerland
[14]
Roche Prod Ltd, Welwyn Garden City, Herts, England
[15]
Univ Rochester, Wilmot Canc Inst, Rochester, NY USA
[16]
Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[17]
Hackensack Univ, Med Ctr, Hackensack, NJ USA
[18]
发布时间
2019-10-16
换一批
